-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EqEkiby65GcWplEefmrsOCyuVO7tMtEGlbW8M9QaYyr3nA7ytqqz2IOu4FX/D2YV 3JvPxD3S6PRIovxPLO5yOQ== 0000732485-05-000063.txt : 20051026 0000732485-05-000063.hdr.sgml : 20051026 20051026130448 ACCESSION NUMBER: 0000732485-05-000063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051025 FILED AS OF DATE: 20051026 DATE AS OF CHANGE: 20051026 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TERMEER HENRI A CENTRAL INDEX KEY: 0001021038 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14680 FILM NUMBER: 051156418 BUSINESS ADDRESS: STREET 1: C/O GENZYME CORP STREET 2: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 ter229.xml X0202 4 2005-10-25 0 0000732485 GENZYME CORP GENZ 0001021038 TERMEER HENRI A GENZYME CORPORATION 500 KENDALL STREET CAMBRIDGE MA 02142 1 1 0 0 Chmn, President and CEO Genzyme common stock (GENZ) 2005-10-25 4 M 0 15000 15.31 A 661934 D Genzyme common stock (GENZ) 2005-10-25 4 M 0 76784 15.13 A 738718 D Genzyme common stock (GENZ) 2005-10-25 4 M 0 141000 15.31 A 879718 D Genzyme common stock (GENZ) 2005-10-25 4 M 0 5816 14.27 A 885534 D Genzyme common stock (GENZ) 2005-10-25 4 M 0 17452 16.29 A 902986 D Genzyme common stock (GENZ) 2005-10-25 4 M 0 145600 13.78 A 1048586 D Genzyme common stock (GENZ) 2005-10-25 4 M 0 5816 7.74 A 1054402 D Genzyme common stock (GENZ) 2005-10-25 4 S 0 15000 71.50 D 1039402 D Genzyme common stock (GENZ) 2005-10-25 4 S 0 392468 71.55 D 646934 D Genzyme common stock (GENZ) 17056 I By 401(k) Genzyme common stock (GENZ) 2371 I By Spouse Genzyme common stock (GENZ) 1256 I By Trust Genzyme NQ stock option (right to buy) 7.74 2005-10-25 4 M 0 5816 0 D 2000-12-14 2005-12-06 Genzyme common stock (GENZ) 5816 0 D Genzyme NQ stock option (right to buy) 15.13 2005-10-25 4 M 0 76784 0 D 1996-05-16 2006-05-16 Genzyme common stock (GENZ) 76784 0 D Genzyme NQ stock option (right to buy) 14.27 2005-10-25 4 M 0 5816 0 D 2000-12-14 2007-05-22 Genzyme common stock (GENZ) 5816 0 D Genzyme NQ stock option (right to buy) 15.31 2005-10-25 4 M 0 15000 0 D 1997-10-16 2007-10-16 Genzyme common stock (GENZ) 15000 141000 D Genzyme NQ stock option (right to buy) 15.31 2005-10-25 4 M 0 141000 0 D 1997-10-16 2007-10-16 Genzyme common stock (GENZ) 141000 0 D Genzyme NQ stock option (right to buy) 16.29 2005-10-25 4 M 0 17452 0 D 2000-12-14 2008-05-27 Genzyme common stock (GENZ) 17452 0 D Genzyme NQ stock option (right to buy) 13.78 2005-10-25 4 M 0 145600 0 D 2002-05-28 2008-05-28 Genzyme common stock (GENZ) 145600 0 D The exercise of this stock option included a distribution of an additional 18 shares of Genzyme common stock. These stock options were entitled to receive a distribution of shares of Tissue Repair common stock that was paid on July 22, 1997 to Genzyme Division stockholders at a rate of 0.015. In connection with the formation of Genzyme Biosurgery in December 2000, shares of Genzyme Tissue Repair were converted into shares of Genzyme Biosurgery at a rate of 0.3352. In connection with the exchange of Genzyme Biosurgery stock into Genzyme stock on June 30, 2003, distributions of the Genzyme Biosurgery stock are exchanged into Genzyme stock at a rate of 0.04945. Outstanding options assumed in the acquisition of GelTex Pharmaceuticals, Inc. on 12/14/00. Reporting person was a member of the GelTex board of directors. Options vest 20% on October 16, 1997 and in 20% annual increments beginning May 16, 1998. Options vest in 20% annual increments beginning on the original date of grant. By: Susan P. Cogswell, Attorney-in-Fact 2005-10-26 -----END PRIVACY-ENHANCED MESSAGE-----